Completed OBSERVATIONAL NCT01716663

CARTO® 3 System and Real Time Intracardiac Ultrasound (IUAF)

CARTO® 3 System and Real Time Intracardiac Ultrasound for Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal AF: Acute Procedural Outcomes Study

Sponsor: Biosense Webster, Inc.

Conditions Atrial Fibrillation Paroxysmal AF

Interventions Catheter Ablation

Updated 6 times since 2017 Last updated: Nov 24, 2014 Started: Oct 31, 2012 Primary completion: Sep 30, 2013 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Atrial Fibrillation and Paroxysmal AF and is currently completed. Biosense Webster, Inc. leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biosense Webster, Inc.

Data source: Biosense Webster, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlantis, United States , Aurora, United States , Gainsville, United States , Hackensack, United States , Houston, United States , Jacksonville, United States , Joliet, United States , Kettering, United States , Kingsport, United States , Kissimmee, United States and 16 more locations